AUDUBON, Pa., April 15, 2019 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced the launch of FORTIFY VA™, a variable angle corpectomy solution, to add to its large and growing Expandable Technology portfolio. Globus Medical is the industry leader in expandable technology with over 20 expandable implant options backed by 15 years of engineering, testing, and clinical experience. The company’s Expandable Technology portfolio consists of the most innovative devices on the market, designed to improve clinical results using minimally invasive surgery (MIS) approaches.
Building on Globus Medical’s experience and innovation, FORTIFY VA™ is an expandable corpectomy spacer designed to optimize anatomical fit using an anterior cervical approach or one of several approaches to the thoracolumbar spine. FORTIFY VA™ provides up to 16° of angulation as the device expands to self-align its variable angle endplate with the patient’s anatomy – an added feature that traditional corpectomy devices do not possess.
Dr. Mike Chen, a neurosurgeon at City of Hope Comprehensive Cancer Center of Duarte, California, recently performed the first FORTIFY VA™ procedure. “Endplate selection is an important factor in restoring sagittal and coronal spinal alignment and providing construct stability. FORTIFY VA™ removes the guesswork in choosing an ideal lordotic or kyphotic implant,” said Dr. Chen. “The ability to provide a customizable implant in fewer steps that is designed to restore height and automatically adjust the endplate to the interfacing vertebra is a significant advancement in expandable corpectomy technology.” 
The Globus Medical Expandable Technology portfolio represents a commitment to advance minimally invasive surgery (MIS), restore sagittal balance, and improve clinical results. To learn more, visit GlobusMedical.com/Expandables.
About Globus Medical, Inc.
Globus Medical, Inc. is a leading musculoskeletal solutions company based in Audubon, PA. The company was founded in 2003 by an experienced team of professionals with a shared vision to create products that enable surgeons to promote healing in patients with musculoskeletal disorders. Additional information can be accessed at http://www.globusmedical.com.
Safe Harbor Statements
All statements included in this press release other than statements of historical fact are forward-looking statements and may be identified by their use of words such as “believe,” “may,” “might,” “could,” “will,” “aim,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan” and other similar terms. These forward-looking statements are based on our current assumptions, expectations and estimates of future events and trends. Forward-looking statements are only predictions and are subject to many risks, uncertainties and other factors that may affect our businesses and operations and could cause actual results to differ materially from those predicted. These risks and uncertainties include, but are not limited to, factors affecting our quarterly results, our ability to manage our growth, our ability to sustain our profitability, demand for our products, our ability to compete successfully (including without limitation our ability to convince surgeons to use our products and our ability to attract and retain sales and other personnel), our ability to rapidly develop and introduce new products, our ability to develop and execute on successful business strategies, our ability to comply with changing laws and regulations that are applicable to our businesses, our ability to safeguard our intellectual property, our success in defending legal proceedings brought against us, trends in the medical device industry, general economic conditions, and other risks. For a discussion of these and other risks, uncertainties and other factors that could affect our results, you should refer to the disclosure contained in our most recent annual report on Form 10-K filed with the Securities and Exchange Commission, including the sections labeled “Risk Factors” and “Cautionary Note Concerning Forward-Looking Statements,” and in our Forms 10-Q, Forms 8-K and other filings with the Securities and Exchange Commission. These documents are available at www.sec.gov. Moreover, we operate in an evolving environment. New risk factors and uncertainties emerge from time to time and it is not possible for us to predict all risk factors and uncertainties, nor can we assess the impact of all factors on its business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on any forward-looking statements. Forward-looking statements contained in this press release speak only as of the date of this press release. We undertake no obligation to update any forward-looking statements as a result of new information, events or circumstances or other factors arising or coming to our attention after the date hereof.
Contact:
Brian Kearns
Senior Vice President, Business Development and Investor Relations
Phone: (610) 930-1800
Email: investors@globusmedical.com
www.globusmedical.com